Signe Diness Vindeløv

Signe Diness Vindeløv

Company: Genmab

Job title: Director, Medical

Seminars:

Live Discussion & Question Time 2:30 pm

Read more

day: Track B - Day 2 PM

Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer: Results from the Phase 2 InnovaTV 204/GOG-3023/ENGOT-cx6 Study 2:10 pm

Review the high unmet need in cervical cancer and educate on tisotumab vedotin MOA Discuss tisotumab vedotin data in recurrent and/or metastatic cervical cancer (innovaTV 201 + innovaTV 204) Provide an overview of TV clinical development plansRead more

day: Track B - Day 2 PM

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.